Pancreas Cancer News and Archives
	Vion Initiates Phase 2 Trial of Triapine(R) and Gemcitabine in Pancreatic Cancer May 28, 2003 Vion Pharmaceuticals, Inc. announced today that it had initiated a new Phase 2 trial of Triapine® in combination with gemcitabine in patients with metastatic or advanced pancreatic cancer. Enrollment of patients began at the Sarah Cannon Cancer Center in Nashville, Tennessee under the direction of Dr. Howard Burris. ...full article
	For educational purposes only; not to be relied upon Please read Pancreatica Disclaimer
	Home | In The News | Links | Newswire | Donations FAQ | Clinical Trials Database | Research Resources | About Us
	webmaster
	©2000-2008 Pancreatica.org - All Rights Reserved www.pancreatica.org